SCHEMBL8416375

SCHEMBL8416375

O=S(=O)(Nc1cc(Cl)nc(N2CCCC2)n1)c1cc[c]cc1

nearest known ligand 0.41

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
GAA P10253 5/20 0.37
L3MBTL1 Q9Y468 3/20 0.37
KMO O15229 4/20 0.36
MAPT P10636 5/20 0.36
KMT2A Q03164 2/20 0.36
TDP1 Q9NUW8 1/20 0.36
LMNA P02545 1/20 0.35
MAPK1 P28482 2/20 0.35
ALDH1A1 P00352 2/20 0.35
MEN1 O00255 1/20 0.35
APAF1 O14727 1/20 0.35
HTT P42858 1/20 0.35
HPGD P15428 1/20 0.34
RECQL P46063 1/20 0.34
GALR2 O43603 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8416384 0.85 HTR6 (0.48) GAAKMOMAPTKMT2AALDH1A1
SCHEMBL7833289 0.83 LMNA (0.50) GAAL3MBTL1MAPTTDP1LMNA
SCHEMBL7838498 0.80 GFER (0.57) GAAL3MBTL1MAPTKMT2ALMNA
SCHEMBL8413419 0.77 HTR6 (0.51) GAAMAPTKMT2ATDP1LMNA
SCHEMBL8413208 0.74 HTR6 (0.54) GAAL3MBTL1MAPTKMT2ALMNA
SCHEMBL8416374 0.72 L3MBTL1 (0.48) GAAL3MBTL1MAPTKMT2AALDH1A1
SCHEMBL8413230 0.71 CES1 (0.44) GAAKMT2ALMNAALDH1A1MEN1
SCHEMBL7823458 0.71 HTR6 (0.68) L3MBTL1KMOMAPTTDP1LMNA
SCHEMBL7823536 0.68 HTR6 (0.68) L3MBTL1MAPTTDP1LMNAALDH1A1
SCHEMBL1697668 0.68 CASP1 (0.48) MAPTKMT2ATDP1MAPK1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5939451-A INDOL-4-YL-BENZENESULFONAMIDES AS ACTIVE MATERIAL TREATING MALARIA, BACTERIAL INFECTION, NEUROLOGICAL DISORDERS HOFFMANN-LA ROCHE INC. (US) 1999-08-17 US disclosed
US-5932599-A 4-AMINO-N-(PYRIDINYL-4-YL)-BENZENESULFONAMIDES AS ACTIVE MATERIAL TREATING MALARIA, BACTERIAL INFECTION, NEUROLOGICAL DISORDERS HOFFMANN-LA ROCHE INC. (US) 1999-08-03 US disclosed